Cassius Ventures Announces Non-Brokered Private Placement
May 14, 2012 08:00 ET | Cassius Ventures Ltd.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 14, 2012) - NOT FOR DISSEMINATION INTO THE UNITED STATES OF AMERICA OR DISTRIBUTION TO U.S. NEWSWIRE SERVICES Cassius...
Eastern Platinum Reports Results for the Three Months Ended March 31, 2012
May 14, 2012 08:00 ET | Eastern Platinum Limited
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 14, 2012) - Mr. Ian Rozier, President and CEO of Eastern Platinum Limited ("Eastplats") (TSX:ELR)(AIM:ELR)(JSE:EPS), reports financial...
VMware,_Inc.-259492564616.jpg
VMware Cloud Infrastructure Validated by SAP for Virtualization of SAP's Database Portfolio
May 14, 2012 08:00 ET | VMware, Inc.
PALO ALTO, CA--(Marketwire - May 14, 2012) - VMware, Inc. (NYSE: VMW), the global leader in virtualization and cloud infrastructure, today announced that SAP® Sybase® Adaptive...
Bryant & Stratton College Online Hosts Free Webinar for Students Interested in HR Careers
May 14, 2012 08:00 ET | Bryant & Stratton College Online
BUFFALO, NY--(Marketwire - May 14, 2012) - Bryant & Stratton College Online, a leader in online associate's degree programs, will host a free webinar for current students enrolled in a human...
BioVentrix selezionata per tenere una presentazione al prestigioso congresso EuroPCR
May 14, 2012 08:00 ET | BioVentrix
PARIS--(Marketwire - May 14, 2012) - BioVentrix, azienda sviluppatrice di terapie minimamente invasive per il trattamento dell’insufficienza cardiaca, è stata selezionata per tenere...
BioVentrix hält Präsentation auf renommierter EuroPCR-Konferenz
May 14, 2012 08:00 ET | BioVentrix
PARIS--(Marketwire - May 14, 2012) - BioVentrix, der Entwickler minimal invasiver Therapien für die Behandlung von Herzinsuffizienz, wurde ausgewählt, eine Präsentation auf der...
BioVentrix est choisie pour réaliser une présentation lors de la prestigieuse réunion d'EuroPCR
May 14, 2012 08:00 ET | BioVentrix
PARIS--(Marketwire - May 14, 2012) - BioVentrix, développeur de traitements minimalement invasifs de l'insuffisance cardiaque, a été choisie pour réaliser une...
BioVentrix geselecteerd om op prestigieuze EuroPCR-bijeenkomst te presenteren
May 14, 2012 08:00 ET | BioVentrix
PARIS--(Marketwire - May 14, 2012) - BioVentrix, de ontwikkelaar van minimaal invasieve therapieën voor de behandeling van hartinfarcten, werd geselecteerd om te presenteren tijdens EuroPCR,...
BioVentrix Selected to Present at Prestigious EuroPCR Meeting
May 14, 2012 08:00 ET | BioVentrix
PARIS--(Marketwire - May 14, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, was selected to present at EuroPCR, the annual meeting of the...
ImmuCell Announces Product Sales Growth and Profit
May 14, 2012 08:00 ET | ImmuCell Corporation
PORTLAND, ME--(Marketwire - May 14, 2012) - ImmuCell Corporation (NASDAQ: ICCC) today announced the results of its operations for the three-month period ended March 31, 2012. During the...